3 reports

  • FEB 24, 2016: PHARMACYTE BIOTECH ON SCHEDULE FOR 2016 CANCER CLINICAL TRIAL IN PANCREATIC CANCER
  • MAY 24, 2016: PHARMACYTE BIOTECH TO ENGAGE PRINCIPAL INVESTIGATOR FOR CLINICAL TRIAL IN PANCREATIC CANCER

Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes.The company’s technology is used for the treatment of advanced and inoperable pancreatic cancer, and diabetes. It develops Cell-in-a-Box cellulose-based...

  • Biotech
  • Cancer
  • Healthcare
  • Pharmaceutical
  • PharmaCyte Biotech, Inc.
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018
  • Toll Like Receptor 8 (CD288 or TLR8) - Therapeutics Development

In this trial, ## patients with PASI scores of ##. ## or greater will be randomized ##:##:##:## to receive weekly subcutaneous doses of IMO-## at ##. ##, ##. ##, or ##. ## mg/ kg/ week or placebo for ## weeks.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Idera Pharmaceuticals, Inc.
  • Toll Like Receptor 8 (CD288 or TLR8) - Therapeutics Development
  • Toll Like Receptor 8 (CD288 or TLR8) - Dormant Products

In this trial, ## patients with PASI scores of ##. ## or greater will be randomized ##:##:##:## to receive weekly subcutaneous doses of IMO-## at ##. ##, ##. ##, or ##. ## mg/ kg/ week or placebo for ## weeks.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Idera Pharmaceuticals, Inc.